The etiologic heterogeneity of schizophrenia

Harvard Review of Psychiatry

Volumn 4, Issue 6, 1997, Pages 317-327

  Garver, David L ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LITHIUM;

AGE; BRAIN ATROPHY; BRAIN DEGENERATION; BRAIN DEVELOPMENT; BRAIN VENTRICLE; CELL MEMBRANE; FAMILY; HUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0030915429     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229709030559     Document Type: Review

References (100)

1. Horrobin DF, Glen AIM, Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res 1994;13:195-207.
2. Kety SS, Rosenthal D, Wender PH, Shulsinger F. The types and prevalence of mental illness in the biologic and adoptive families of adopted schizophrenics. J Psychiatry Res 1968;1: 345-62.
3. Kendler KS, Gruenberg AM, Tsuang MT. Psychiatric illness in first degree relatives of schizophrenic and surgical control patients. Arch Gen Psychiatry 1985;42:770-9.
4. Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL, et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 1995;60:252-60.
5. Lichter JB, Cardon L, Crow T, DeLisi L. Identification of susceptibility genes for schizophrenia [Abstract]. Psychiatr Genet 1995;5(suppl 1):S39.
6. Arolt V, Purmann S, Nolte A, Lencer R, Leutelt J, Muller B, et al. Possible linkage of ETD and markers on chromosome 6p [Abstract]. Psychiatr Genet 1995;5(suppl 1):S33.
7. Wang S, Sun CE, Walczak CA, Ziegle JS, Kipps BR, Goldin LR, et al. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 1995;10:41-6.
8. Moises HW, Kristbjarnarson H, Yang L, Wiese C, Arolt V, Schwinger E, et al. A two-stage genome-wide search for schizophrenia susceptibility genes [Abstract]. Psychiatr Genet 1995;5(suppl 1):S33.
9. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. Am J Med Genet 1994;54:36-43.
10. Coon H, Holik J, Hoff M, Reimherr F, Wender P, Myles-Worsley M, et al. Analysis of chromosome 22 markers in nine schizophrenia pedigrees. Am J Med Genet 1994;54:72-9.
11. Polymeropoulos MH, Devoto M, Rubenstein J, Lofthouse R, Smith A, Shields G, et al. A random search of the genome in nuclear families with schizophrenia [Abstract]. Psychiatr Genet 1995;5(suppl 1):S51.
12. Cowen MA, Green M. The Kallmann's syndrome variant (KSV) model of the schizophrenias. Schizophr Res 1993;9:1-10.
13. Zipursky RB, Schulz SC. Seasonality of birth and CT findings in schizophrenia. Biol Psychiatry 1987;22:1288-92.
14. Mednick SA, Machon RA, Huttunen MO, Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988;45:189-92.
15. Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normethanephrine in mouse brain. Acta Pharmacol Toxicol 1963;20: 140-4.
16. Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 1970;11:303-14.
17. Bowers MB Jr, Swigar ME, Jatlow PI, Goicoechea N. Plasma catecholamine metabolites and early response to haloperidol. J Clin Psychiatry 1984;45:248-51.
18. Bowers MB Jr, Swigar ME, Jatlow PI, Hoffman F, Goicoechea N. Early neuroleptic response in psychotic men and women: correlation with plasma HVA and MHPG. Compr Psychiatry 1986;27:181-5.
19. Van Putten T, Marder SR, Aravagiri M, Chabert N, Mintz J. Plasma homovanillic acid as a predictor of response to fluphenazine treatment. Psychol Bull 1989;1:89-91.
20. Koreen AR, Lieberman J, Alvir J, Mayerhoff D, Loebel A, Chakos M, et al. Plasma homovanillic acid levels in first-episode schizophrenia: psychopathology and treatment response. Arch Gen Psychiatry 1994;51:132-8.
21. Garver DL, Steinberg JL, McDermott BE, Yao JK, Ramberg JE, Lewis S, et al. Etiologic heterogeneity of the psychoses: is there a dopamine psychosis? Neuropsychopharmacology [In press].
22. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Press, 1980.
23. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia (SADS). Arch Gen Psychiatry 1978;35:837-44.
24. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
25. Wolf ME, Roth RH. Autoreceptor regulation of dopamine synthesis. Ann N Y Acad Sci 1990;604:323-43.
26. Nordström AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 1993;33:227-35.
27. Jacobi W, Winkler H. Encephalographische Studien an Schizophrenen. Arch Psychiatrie 1928;84:208-26.
28. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976;2:924-6.
29. Weinberger DR, Torrey EF, Neophytides AN, Wyatt RJ. Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry 1979;36:735-9.
30. Coffman JA. Computed tomography in psychiatry. In: Andreasen NC, ed. Brain imaging: application in psychiatry. Washington, DC: American Psychiatric Press, 1989:1-65.
31. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med 1992;327:604-12.
32. Bogerts B, Meertz E, Schönfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 1985;42:784-91.
33. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res 1992;7:95-100.
34. Andreasen NC, Arndt S, Swayze V, Cizadlo T, Flaum M, O'Leary D, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994;266:294-8.
35. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 1992;49: 921-6.
36. Kemali D, Maj M, Galderisi S, Milici N, Salvati A. Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study. Biol Psychiatry 1989;26:756-9.
37. Woods BT, Yurgelun-Todd D, Benes FM, Frankenburg FR, Pope HG Jr, McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry 1990; 27:341-52.
38. Jaskiw GE, Juliano DM, Goldberg TE, Hertzman M, Urow-Hamell E, Weinberger DR. Cerebral ventricular enlargement in schizophreniform disorder does not progress: a seven year follow-up study. Schizophr Res 1994;14:23-8.
39. Vita A, Giobbio GM, Dieci M, Garbarini M, Morganti C, Comazzi M, et al. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. Biol Psychiatry 1994;35:960-2.
40. Knoll JL IV, Garver DL, Ramberg JE, Kingsbury SJ, Croissant D, McDermott B. Heterogeneity of the psychoses: is there a neurodegenerative psychosis? Schizophr Bull [In press].
41. Pettegrevv JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics: a pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 1991;48:563-8.
42. 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand 1992; 86:455-62.
43. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biol Psychiatry 1994;36:503-10.
44. Shioiri T, Kato T, Inubushi T, Murashita J, Takahashi S. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Res 1994;55:223-35.
45. 31P-MR spectroscopy study. Schizophr Res 1994;13:209-16.
46. Pakkenberg B. Stereological quantitation of human brains from normal and schizophrenic individuals. Acta Neurol Scand Suppl 1992;137:20-33.
47. Kaplan MJ, Lazoff M, Kelly K, Lukin R, Garver DL. Enlargement of cerebral third ventricle in psychotic patients with delayed response to neuroleptics. Biol Psychiatry 1990;27: 205-14.
48. Zemlan FP, Hirschowitz J, Sautter FJ, Garver DL. Impact of lithium therapy on core psychotic symptoms. Br J Psychiatry 1984;144:64-9.
49. Garver DL, Kelly K, Fried KA, Magnusson M, Hirschowitz J. Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias). Psychol Med 1988;18:873-85.
50. Barron SA, Jacobs L, Kinkel WR. Changes in size of normal lateral ventricles during aging determined by computerized tomography. Neurology 1976;26:1011-3.
51. Bunney BS. Effects of acute and chronic neuroleptic treatment on the activity of midbrain dopamine neurons. Ann N Y Acad Sci 1988;537:77-85.
52. Loebel A, Lieberman J, Alvir J, Geisler J, Koreen A, Chakos M. Time to treatment response in successive episodes of early-onset schizophrenia [Abstract]. Schizophr Res 1995;15: 158.
53. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, et al. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry 1993;33:255-60.
54. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;43:1097-105.
55. Mahadik SP, Mukherjee S, Correnti EE, Scheffer R. Elevated levels of lipid peroxidation products in plasma of drug-naive patients at the onset of psychosis [Abstract]. Schizophr Res 1995;15:66.
56. 3H]GBR 12935 binding site density in the prefrontal cortex of controls and schizophrenics. Biol Psychiatry 1995;37:175-82.
57. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
58. Cowan WM, Fawcett JW, O'Leary DDM, Stanfield BB. Regressive events in neurogenesis. Science 1984;225:1258-65.
59. Wood KA, Youle RJ. Apoptosis and free radicals. Ann N Y Acad Sci 1994;738:400-7.
60. Barde YA. Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 1994;390:45-56.
61. Roberts GW. Schizophrenia: a neuropathological perspective. Br J Psychiatry 1991;158:8-17.
62. Stevens JR. Neuropathology of schizophrenia. Arch Gen Psychiatry 1982;39:1131-9.
63. Sautter F, McDermott B, Garver D. Familial differences between rapid neuroleptic response psychosis and delayed neuroleptic response psychosis. Biol Psychiatry 1993;33:15-21.
64. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991;48:625-32.
65. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991;48:996-1001.
66. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. Arch Gen Psychiatry 1995;52:805-18.
67. Kovelman JA, Scheibel AB. A neurohistological correlate of schizophrenia. Biol Psychiatry 1984;19:1601-21.
68. Barbeau D, Liang JJ, Robitaille Y, Quirion R, Srivastava LK. Decreased expression of the embryonic forms of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A 1995;92:2785-9.
69. Fish B. Infant predictors of the longitudinal course of schizophrenic development. Schizophr Bull 1987;13:395-409.
70. Rakic P. Mode of cell migration to the superficial layers of fetal monkey neocortex. J Comp Neurol 1972;145:61-83.
71. Edelman GM, Chuong CM. Embryonic to adult conversion of neural cell adhesion molecules in normal and staggerer mice. Proc Natl Acad Sci U S A 1982;79:7036-40.
72. Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986;65:303-26.
73. DeLisi LE, Dauphinais D, Gershon ES. Perinatal complications and reduced size of brain limbic structures in familial schizophrenia. Schizophr Bull 1988;14:185-216.
74. McCarley RW, Shenton ME, O'Donnell BF, Faux SF, Kikinis R, Nestor PG, et al. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry 1993;50:190-7.
75. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry 1992;49:195-205.
76. Schulz SC, Sinicrope P, Kishore P, Friedel RO. Treatment response and ventricular brain enlargement in young schizophrenic patients. Psychopharmacol Bull 1983;19:510-2.
77. Yakeley J, Murray RM. Genetic and environmental risk factors for schizophrenia. In: Brunello N, Racagni G, Langer SZ, Mendlewicz J, eds. Critical issues in the treatment of schizophrenia. Basel: Karger, 1995:9-34.
78. O'Callaghan E, Sham P, Takei N, Glover G, Murray RM. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 1991;337:1248-50.
79. Kunugi H, Nanko S, Takei N. Influenza and schizophrenia in Japan [Letter]. Br J Psychiatry 1992;161:274-5.
80. Torrey EF, Bowler AE, Rawlings R. Schizophrenia and the 1957 influenza epidemic [Abstract]. Schizophr Res 1992;6: 100.
81. Susser E, Lin SP, Brown AS, Lumey LH, Erlenmeyer-Kimling L. No relation between risk of schizophrenia and prenatal exposure to influenza in Holland. Am J Psychiatry 1994;151: 992-4.
82. Conrad AJ, Scheibel AB. Schizophrenia and the hippocampus: the embryological hypothesis extended. Schizophr Bull 1987; 13:577-87.
83. Bradbury TN, Miller GA. Season of birth in schizophrenia: a review of evidence, methodology and etiology. Psychol Bull 1985;98:569-94.
84. Shur E. Season of birth in high and low genetic risk schizophrenia. Br J Psychiatry 1981;140:410-5.
85. O'Callaghan E, Gibson T, Colohan HA, Walshe D, Buckley P, Larkin C, et al. Season of birth in schizophrenia: evidence for confinement of an excess of winter births to patients without a family history of mental disorder. Br J Psychiatry 1991;158: 764-9.
86. Roy MA, Flaum MA, Gupta S, Jaramillo L, Andreasen NC. Epidemiological and clinical correlates of familial and sporadic schizophrenia. Acta Psychiatr Scand 1994;89:324-8.
87. Sautter F, Garver DL. Familial differences in lithium responsive vs. lithium non-responsive psychoses. J Psychiatr Res 1984;19:1-8.
88. Garver DL, Hutchinson LJ. Psychosis, lithium-induced antipsychotic response, and seasonality. Psychiatry Res 1988;26: 279-86.
89. Schexnayder LW, Hirschowitz J, Sautter FJ, Garver DL. Predictors of response to lithium in patients with psychoses. Am J Psychiatry 1995;152:1511-3.
90. Edelstein P, Schultz JB, Hirschowitz J, Kanter DR, Garver DL. Physostigmine and lithium response in the schizophrenias. Am J Psychiatry 1981;138:1078-81.
91. Hitzemann R, Mark C, Hirschowitz J, Garver D. Characteristics of phospholipid methylation in human erythrocyte ghosts: relationship(s) to the psychoses and affective disorders. Biol Psychiatry 1985;20:397-407.
92. Hitzemann R, Mark C, Hirschowitz J, Garver D. RBC lithium transport in the psychoses. Biol Psychiatry 1989; 25:296-304.
93. Bleuler E. Dementia praecox or the group of schizophrenias [German edition published in 1911; Zinkin J, transl]. New York, International Universities Press, 1950.
94. Kendell RE, Cooper JE, Gourlay AJ, Copeland JRM. Diagnostic criteria of American and British psychiatrists. Arch Gen Psychiatry 1971;25:123-30.
95. Stephens JH, Astrup C. Prognosis in "process" and "non-process" schizophrenia. Am J Psychiatry 1963;119:945-53.
96. Tsuang MT, Winokur G. Criteria for subtyping schizophrenia. Arch Gen Psychiatry 1974;31:43-7.
97. Crow TJ. Molecular pathology of schizophrenia: more than one disease process? BMJ 1980;280:66-8.
98. Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 1982;39:784-8.
99. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia: methods, meanings, and mechanisms. Arch Gen Psychiatry 1995;52:341-51.
100. Garver DL, Reich T, Isenberg KE, Cloninger CR. Schizophrenia and the question of genetic heterogeneity. Schizophr Bull 1989;15:421-9.